More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of cancer …

Infection with human papillomavirus (HPV) is recognized as one of the major causes of
infection-related cancer worldwide, as well as the causal factor in other diseases. Strong …

European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated
in the Europe Against Cancer Programme. The first edition established the principles of …

Background Meta-analyses have become an essential tool in synthesizing evidence on clinical
and epidemiological questions derived from a multitude of similar studies assessing the …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Background The knowledge that persistent human papillomavirus infection is the main cause
of cervical cancer has resulted in the development of assays that detect nucleic acids of …

Background Tracking progress and providing timely evidence is a fundamental step forward
for countries to remain aligned with the targets set by WHO to eliminate cervical cancer as a …

Background To limit the spread of SARS-CoV-2, an evidence-based understanding of the
symptoms is critical to inform guidelines for quarantining and testing. The most common …

Given the strong etiologic link between high‐risk HPV infection and cervical cancer high‐risk
HPV testing is now being considered as an alternative for cytology‐based cervical cancer …